αααααβααΎαRIG2 β’ FRA
add
Gedeon Richter Ord Shs
26.50β¬
16 α§αααΆ, 10:59:59 PM ααααβααα +2 · EUR · FRA · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
25.60β¬
α
αααααααααααα
26.14β¬ - 26.50β¬
α
ααααααα½αααααΆαα
α»αααααα
22.94β¬ - 28.32β¬
ααα ααα½αααΌαααααα
506.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααααααΆαααΈααααΆα
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
(HUF) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌα | 224.02Β αααΈααΆα | 10.12% |
α
αααΆαααααα·ααααα·ααΆα | 87.41Β αααΈααΆα | 11.22% |
α
αααΌααα»ααα | 68.14Β αααΈααΆα | -0.11% |
ααααΆααα
αααααα»ααα | 30.42 | -9.28% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 81.81Β αααΈααΆα | 8.83% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 16.84% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
(HUF) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 201.78Β αααΈααΆα | 97.83% |
ααααααααα»α | 1.63Β ααααΈααΆα | 14.46% |
ααΆαααα½ααα»αααααΌαααα»α | 282.79Β αααΈααΆα | 26.01% |
ααΌαβααααα»α | 1.35Β ααααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 182.68Β ααΆα | β |
ααααααααααΉαααααα
| 0.00 | β |
ααα
ααααααΎαααααα | 10.49% | β |
ααα
ααααααΎααΎααα»α | 11.96% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
(HUF) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
---|---|---|
α
αααΌααα»ααα | 68.14Β αααΈααΆα | -0.11% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 63.41Β αααΈααΆα | 10.41% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | 5.42Β αααΈααΆα | 114.85% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -1.70Β αααΈααΆα | 78.15% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | 65.38Β αααΈααΆα | 380.67% |
ααα αΌαααΆα
αααααΆααααααα | 3.87Β αααΈααΆα | -86.71% |
α’αααΈ
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
ααΆααααααΎαα‘αΎα
1901
αααααβαααααΆα
αα»ααααα·α
10,943